This Amendment No. 18 to Schedule 13D is being filed on behalf of DBSI Investments Ltd. ("DBSI"), Barak Dotan and Yossi Ben Shalom (together, the “Reporting Persons”), relating to the ordinary shares (the “Ordinary Shares”) of Pointer Telocation Ltd., a corporation existing under the laws of Israel (“Pointer”). The original statement on Schedule 13D, and the previous amendments filed thereto, are hereby amended and supplemented as follows:
Item 4. Purpose of Transaction
Item 4 of the Schedule 13D is hereby amended by adding the following:
On December 23, 2013, DBSI entered into a Rule 10b5-1 Trading Plan pursuant to Rule 10b5-1(c)(1) under the Securities Exchange Act of 1934, as amended (the “10b5-1 Plan”). The description of the 10b5-1 Plan set forth in Item 6 below is incorporated herein by reference in its entirety.
Item 5. Interest in Securities of the Issuer.
(a) (b) DBSI is the beneficial owner of 2,763,194 Ordinary Shares, constituting 49.65% of the outstanding Ordinary Shares. Messrs. Yossi Ben Shalom and Barak Dotan, by virtue of their relationship with and interests in DBSI, may be deemed to control DBSI and consequently share the beneficial ownership of 2,763,194 Ordinary Shares. DBSI holds the right to vote its 2,763,194 Ordinary Shares, which right is directed jointly by Messrs. Yossi Ben Shalom and Barak Dotan.
(c) The list of all purchases or sales of Ordinary Shares by the Reporting Persons in the last 60 days is hereby amended by adding the following transactions made pursuant to DBSI’s 10b5-1 plan:
(i) On January 6, 2014, DBSI sold 31,200 Ordinary Shares in open market transactions at a weighted average price of $12.05438* per share.
(ii) On January 7, 2014, DBSI sold 18,800 Ordinary Shares in open market transactions at a weighted average price of $12.17883* per share.
(iii) On January 8, 2014, DBSI sold 14,800 Ordinary Shares in open market transactions at a weighted average price of $12.09267* per share.
(iv) On January 10, 2014, DBSI sold 17,100 Ordinary Shares in open market transactions at a weighted average price of $12.23452* per share.
(*) Upon request, the Reporting Person will provide the Staff with full information regarding the number of shares sold at each separate price. |
(d) Not applicable.
(e) Not applicable.
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer
Item 6 of the Schedule 13D is hereby amended by adding the following:
On December 23, 2013, DBSI entered into a 10b5-1 Plan with Oppenheimer. Under the 10b5-1 Plan, beginning on January 6, 2014 and ending on June 30, 2014, Oppenheimer is authorized to sell, on behalf of DBSI, up to an aggregate of 1,354,634 shares, subject to the parameters of the 10b5-1 Plan. All sales under the 10b5-1 Plan are to be made in accordance with the terms, conditions and restrictions of the 10b5-1 Plan and DBSI shall not have any control, influence or authority over sales made pursuant to the 10b5-1 Plan.
Item 7. Materials to be Filed as Exhibits.
Exhibit 1. Joint Filing Agreement